nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Methotrexate—germ cell cancer	0.239	0.308	CbGbCtD
Meloxicam—PTGS1—Ifosfamide—germ cell cancer	0.104	0.134	CbGbCtD
Meloxicam—ABCC4—Methotrexate—germ cell cancer	0.066	0.085	CbGbCtD
Meloxicam—CYP2C8—Ifosfamide—germ cell cancer	0.0598	0.0771	CbGbCtD
Meloxicam—PTGS2—Cisplatin—germ cell cancer	0.0597	0.077	CbGbCtD
Meloxicam—PTGS2—Etoposide—germ cell cancer	0.0587	0.0756	CbGbCtD
Meloxicam—PTGS1—Etoposide—germ cell cancer	0.0496	0.0639	CbGbCtD
Meloxicam—CYP2C9—Ifosfamide—germ cell cancer	0.0417	0.0538	CbGbCtD
Meloxicam—CYP2C8—Etoposide—germ cell cancer	0.0286	0.0369	CbGbCtD
Meloxicam—CYP3A4—Ifosfamide—germ cell cancer	0.0243	0.0313	CbGbCtD
Meloxicam—CYP2C9—Cisplatin—germ cell cancer	0.0203	0.0262	CbGbCtD
Meloxicam—CYP3A4—Vinblastine—germ cell cancer	0.0129	0.0166	CbGbCtD
Meloxicam—CYP3A4—Etoposide—germ cell cancer	0.0116	0.0149	CbGbCtD
Meloxicam—CYP2C9—cardial valve—germ cell cancer	0.00966	0.158	CbGeAlD
Meloxicam—CYP2C9—urine—germ cell cancer	0.00208	0.0342	CbGeAlD
Meloxicam—PTGS2—appendage—germ cell cancer	0.00177	0.029	CbGeAlD
Meloxicam—PGD—neck—germ cell cancer	0.00176	0.0289	CbGeAlD
Meloxicam—CYP3A4—urine—germ cell cancer	0.00159	0.0261	CbGeAlD
Meloxicam—PGD—trigeminal ganglion—germ cell cancer	0.00152	0.0249	CbGeAlD
Meloxicam—PTGS2—skin epidermis—germ cell cancer	0.00147	0.0242	CbGeAlD
Meloxicam—PGD—eye—germ cell cancer	0.00131	0.0215	CbGeAlD
Meloxicam—PGD—retina—germ cell cancer	0.0013	0.0213	CbGeAlD
Meloxicam—PTGS1—ganglion—germ cell cancer	0.0013	0.0213	CbGeAlD
Meloxicam—PGD—telencephalon—germ cell cancer	0.00119	0.0196	CbGeAlD
Meloxicam—PGD—skin of body—germ cell cancer	0.00114	0.0187	CbGeAlD
Meloxicam—PGD—decidua—germ cell cancer	0.00113	0.0186	CbGeAlD
Meloxicam—PTGS1—endothelium—germ cell cancer	0.00112	0.0183	CbGeAlD
Meloxicam—PTGS2—endothelium—germ cell cancer	0.00107	0.0175	CbGeAlD
Meloxicam—PTGS1—blood vessel—germ cell cancer	0.00103	0.0169	CbGeAlD
Meloxicam—PGD—gonad—germ cell cancer	0.000997	0.0164	CbGeAlD
Meloxicam—PGD—uterus—germ cell cancer	0.00099	0.0162	CbGeAlD
Meloxicam—PTGS2—blood vessel—germ cell cancer	0.000985	0.0162	CbGeAlD
Meloxicam—PGD—pituitary gland—germ cell cancer	0.000972	0.016	CbGeAlD
Meloxicam—PGD—medulla oblongata—germ cell cancer	0.000938	0.0154	CbGeAlD
Meloxicam—PGD—adrenal gland—germ cell cancer	0.000869	0.0143	CbGeAlD
Meloxicam—PGD—midbrain—germ cell cancer	0.000858	0.0141	CbGeAlD
Meloxicam—PGD—bone marrow—germ cell cancer	0.00084	0.0138	CbGeAlD
Meloxicam—PGD—spinal cord—germ cell cancer	0.000837	0.0137	CbGeAlD
Meloxicam—PGD—female gonad—germ cell cancer	0.00081	0.0133	CbGeAlD
Meloxicam—PGD—endocrine gland—germ cell cancer	0.000753	0.0124	CbGeAlD
Meloxicam—PGD—head—germ cell cancer	0.000744	0.0122	CbGeAlD
Meloxicam—PGD—testis—germ cell cancer	0.000718	0.0118	CbGeAlD
Meloxicam—ABCC4—uterus—germ cell cancer	0.000704	0.0116	CbGeAlD
Meloxicam—PGD—cerebellum—germ cell cancer	0.000664	0.0109	CbGeAlD
Meloxicam—ABCC4—adrenal gland—germ cell cancer	0.000618	0.0101	CbGeAlD
Meloxicam—PTGS2—trigeminal ganglion—germ cell cancer	0.000609	0.00999	CbGeAlD
Meloxicam—ABCC4—bone marrow—germ cell cancer	0.000598	0.00981	CbGeAlD
Meloxicam—PTGS2—embryo—germ cell cancer	0.000588	0.00964	CbGeAlD
Meloxicam—ABCC4—female gonad—germ cell cancer	0.000576	0.00945	CbGeAlD
Meloxicam—PGD—brain—germ cell cancer	0.000539	0.00884	CbGeAlD
Meloxicam—ABCC4—endocrine gland—germ cell cancer	0.000536	0.00879	CbGeAlD
Meloxicam—ABCC4—head—germ cell cancer	0.000529	0.00868	CbGeAlD
Meloxicam—PGD—lymph node—germ cell cancer	0.000521	0.00854	CbGeAlD
Meloxicam—ABCC4—testis—germ cell cancer	0.000511	0.00838	CbGeAlD
Meloxicam—CYP2C8—pituitary gland—germ cell cancer	0.000502	0.00824	CbGeAlD
Meloxicam—PTGS1—telencephalon—germ cell cancer	0.0005	0.0082	CbGeAlD
Meloxicam—PTGS2—telencephalon—germ cell cancer	0.000478	0.00784	CbGeAlD
Meloxicam—PTGS1—skin of body—germ cell cancer	0.000477	0.00783	CbGeAlD
Meloxicam—PTGS2—skin of body—germ cell cancer	0.000456	0.00748	CbGeAlD
Meloxicam—PTGS1—uterus—germ cell cancer	0.000415	0.0068	CbGeAlD
Meloxicam—PTGS1—pituitary gland—germ cell cancer	0.000407	0.00668	CbGeAlD
Meloxicam—PTGS2—uterus—germ cell cancer	0.000396	0.0065	CbGeAlD
Meloxicam—PTGS2—pituitary gland—germ cell cancer	0.000389	0.00639	CbGeAlD
Meloxicam—CYP2C8—endocrine gland—germ cell cancer	0.000389	0.00638	CbGeAlD
Meloxicam—ABCC4—brain—germ cell cancer	0.000383	0.00629	CbGeAlD
Meloxicam—PTGS2—medulla oblongata—germ cell cancer	0.000376	0.00616	CbGeAlD
Meloxicam—CYP2C8—testis—germ cell cancer	0.000371	0.00609	CbGeAlD
Meloxicam—ABCC4—lymph node—germ cell cancer	0.00037	0.00608	CbGeAlD
Meloxicam—PTGS1—adrenal gland—germ cell cancer	0.000364	0.00597	CbGeAlD
Meloxicam—PTGS1—spinal cord—germ cell cancer	0.00035	0.00575	CbGeAlD
Meloxicam—PTGS2—adrenal gland—germ cell cancer	0.000348	0.0057	CbGeAlD
Meloxicam—CYP2C9—endocrine gland—germ cell cancer	0.000346	0.00567	CbGeAlD
Meloxicam—PTGS2—midbrain—germ cell cancer	0.000343	0.00563	CbGeAlD
Meloxicam—PTGS1—female gonad—germ cell cancer	0.000339	0.00556	CbGeAlD
Meloxicam—PTGS2—bone marrow—germ cell cancer	0.000336	0.00552	CbGeAlD
Meloxicam—PTGS2—spinal cord—germ cell cancer	0.000335	0.00549	CbGeAlD
Meloxicam—PTGS2—female gonad—germ cell cancer	0.000324	0.00532	CbGeAlD
Meloxicam—PTGS1—endocrine gland—germ cell cancer	0.000315	0.00518	CbGeAlD
Meloxicam—PTGS1—head—germ cell cancer	0.000311	0.00511	CbGeAlD
Meloxicam—PTGS2—endocrine gland—germ cell cancer	0.000302	0.00495	CbGeAlD
Meloxicam—Erythema multiforme—Etoposide—germ cell cancer	0.000301	0.00185	CcSEcCtD
Meloxicam—Paraesthesia—Bleomycin—germ cell cancer	0.000301	0.00184	CcSEcCtD
Meloxicam—PTGS1—testis—germ cell cancer	0.000301	0.00494	CbGeAlD
Meloxicam—Dyspnoea—Bleomycin—germ cell cancer	0.000299	0.00183	CcSEcCtD
Meloxicam—Myalgia—Ifosfamide—germ cell cancer	0.000299	0.00183	CcSEcCtD
Meloxicam—Arthralgia—Ifosfamide—germ cell cancer	0.000299	0.00183	CcSEcCtD
Meloxicam—Renal failure acute—Methotrexate—germ cell cancer	0.000299	0.00183	CcSEcCtD
Meloxicam—Flatulence—Cisplatin—germ cell cancer	0.000298	0.00183	CcSEcCtD
Meloxicam—PTGS2—head—germ cell cancer	0.000298	0.00488	CbGeAlD
Meloxicam—Eye disorder—Etoposide—germ cell cancer	0.000298	0.00182	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000297	0.00182	CcSEcCtD
Meloxicam—Flushing—Etoposide—germ cell cancer	0.000296	0.00181	CcSEcCtD
Meloxicam—Cardiac disorder—Etoposide—germ cell cancer	0.000296	0.00181	CcSEcCtD
Meloxicam—Discomfort—Ifosfamide—germ cell cancer	0.000295	0.00181	CcSEcCtD
Meloxicam—Hypersensitivity—Vinblastine—germ cell cancer	0.000292	0.00179	CcSEcCtD
Meloxicam—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000292	0.00179	CcSEcCtD
Meloxicam—Decreased appetite—Bleomycin—germ cell cancer	0.000291	0.00179	CcSEcCtD
Meloxicam—Visual disturbance—Methotrexate—germ cell cancer	0.000291	0.00178	CcSEcCtD
Meloxicam—Muscle spasms—Cisplatin—germ cell cancer	0.000291	0.00178	CcSEcCtD
Meloxicam—Angiopathy—Etoposide—germ cell cancer	0.000289	0.00177	CcSEcCtD
Meloxicam—Confusional state—Ifosfamide—germ cell cancer	0.000289	0.00177	CcSEcCtD
Meloxicam—Immune system disorder—Etoposide—germ cell cancer	0.000288	0.00176	CcSEcCtD
Meloxicam—Mediastinal disorder—Etoposide—germ cell cancer	0.000287	0.00176	CcSEcCtD
Meloxicam—Pain—Bleomycin—germ cell cancer	0.000287	0.00176	CcSEcCtD
Meloxicam—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000286	0.00176	CcSEcCtD
Meloxicam—Oedema—Ifosfamide—germ cell cancer	0.000286	0.00176	CcSEcCtD
Meloxicam—Vision blurred—Cisplatin—germ cell cancer	0.000285	0.00175	CcSEcCtD
Meloxicam—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000285	0.00175	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000285	0.00175	CcSEcCtD
Meloxicam—Asthenia—Vinblastine—germ cell cancer	0.000285	0.00175	CcSEcCtD
Meloxicam—Infection—Ifosfamide—germ cell cancer	0.000285	0.00174	CcSEcCtD
Meloxicam—Tremor—Cisplatin—germ cell cancer	0.000284	0.00174	CcSEcCtD
Meloxicam—Alopecia—Etoposide—germ cell cancer	0.000281	0.00172	CcSEcCtD
Meloxicam—Nervous system disorder—Ifosfamide—germ cell cancer	0.000281	0.00172	CcSEcCtD
Meloxicam—Ill-defined disorder—Cisplatin—germ cell cancer	0.000281	0.00172	CcSEcCtD
Meloxicam—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00028	0.00172	CcSEcCtD
Meloxicam—Anaemia—Cisplatin—germ cell cancer	0.00028	0.00171	CcSEcCtD
Meloxicam—CYP2C8—brain—germ cell cancer	0.000278	0.00457	CbGeAlD
Meloxicam—Skin disorder—Ifosfamide—germ cell cancer	0.000278	0.00171	CcSEcCtD
Meloxicam—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000277	0.0017	CcSEcCtD
Meloxicam—Feeling abnormal—Bleomycin—germ cell cancer	0.000276	0.00169	CcSEcCtD
Meloxicam—Malaise—Cisplatin—germ cell cancer	0.000273	0.00167	CcSEcCtD
Meloxicam—Decreased appetite—Dactinomycin—germ cell cancer	0.000272	0.00167	CcSEcCtD
Meloxicam—Diarrhoea—Vinblastine—germ cell cancer	0.000272	0.00166	CcSEcCtD
Meloxicam—Dysgeusia—Etoposide—germ cell cancer	0.000271	0.00166	CcSEcCtD
Meloxicam—Leukopenia—Cisplatin—germ cell cancer	0.000271	0.00166	CcSEcCtD
Meloxicam—Fatigue—Dactinomycin—germ cell cancer	0.00027	0.00165	CcSEcCtD
Meloxicam—Back pain—Etoposide—germ cell cancer	0.000268	0.00164	CcSEcCtD
Meloxicam—Hypotension—Ifosfamide—germ cell cancer	0.000268	0.00164	CcSEcCtD
Meloxicam—Pain—Dactinomycin—germ cell cancer	0.000267	0.00164	CcSEcCtD
Meloxicam—Muscle spasms—Etoposide—germ cell cancer	0.000267	0.00163	CcSEcCtD
Meloxicam—Urticaria—Bleomycin—germ cell cancer	0.000266	0.00163	CcSEcCtD
Meloxicam—PTGS2—cerebellum—germ cell cancer	0.000266	0.00436	CbGeAlD
Meloxicam—Body temperature increased—Bleomycin—germ cell cancer	0.000265	0.00162	CcSEcCtD
Meloxicam—CYP3A4—endocrine gland—germ cell cancer	0.000264	0.00432	CbGeAlD
Meloxicam—Dizziness—Vinblastine—germ cell cancer	0.000262	0.00161	CcSEcCtD
Meloxicam—Convulsion—Cisplatin—germ cell cancer	0.000262	0.00161	CcSEcCtD
Meloxicam—Mood swings—Methotrexate—germ cell cancer	0.000261	0.0016	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000261	0.0016	CcSEcCtD
Meloxicam—Myalgia—Cisplatin—germ cell cancer	0.000258	0.00158	CcSEcCtD
Meloxicam—Feeling abnormal—Dactinomycin—germ cell cancer	0.000258	0.00158	CcSEcCtD
Meloxicam—Paraesthesia—Ifosfamide—germ cell cancer	0.000257	0.00158	CcSEcCtD
Meloxicam—Ill-defined disorder—Etoposide—germ cell cancer	0.000257	0.00158	CcSEcCtD
Meloxicam—Anxiety—Cisplatin—germ cell cancer	0.000257	0.00157	CcSEcCtD
Meloxicam—Anaemia—Etoposide—germ cell cancer	0.000256	0.00157	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000256	0.00157	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000256	0.00157	CcSEcCtD
Meloxicam—Dyspnoea—Ifosfamide—germ cell cancer	0.000255	0.00157	CcSEcCtD
Meloxicam—Somnolence—Ifosfamide—germ cell cancer	0.000255	0.00156	CcSEcCtD
Meloxicam—Liver function test abnormal—Methotrexate—germ cell cancer	0.000255	0.00156	CcSEcCtD
Meloxicam—Discomfort—Cisplatin—germ cell cancer	0.000255	0.00156	CcSEcCtD
Meloxicam—Vomiting—Vinblastine—germ cell cancer	0.000252	0.00155	CcSEcCtD
Meloxicam—Malaise—Etoposide—germ cell cancer	0.00025	0.00153	CcSEcCtD
Meloxicam—Vertigo—Etoposide—germ cell cancer	0.000249	0.00153	CcSEcCtD
Meloxicam—Decreased appetite—Ifosfamide—germ cell cancer	0.000249	0.00153	CcSEcCtD
Meloxicam—Headache—Vinblastine—germ cell cancer	0.000249	0.00152	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000248	0.00152	CcSEcCtD
Meloxicam—Leukopenia—Etoposide—germ cell cancer	0.000248	0.00152	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000247	0.00152	CcSEcCtD
Meloxicam—Body temperature increased—Dactinomycin—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Abdominal pain—Dactinomycin—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Fatigue—Ifosfamide—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Anaphylactic shock—Cisplatin—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Oedema—Cisplatin—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Hypersensitivity—Bleomycin—germ cell cancer	0.000247	0.00151	CcSEcCtD
Meloxicam—Infection—Cisplatin—germ cell cancer	0.000245	0.0015	CcSEcCtD
Meloxicam—Constipation—Ifosfamide—germ cell cancer	0.000245	0.0015	CcSEcCtD
Meloxicam—Pain—Ifosfamide—germ cell cancer	0.000245	0.0015	CcSEcCtD
Meloxicam—Loss of consciousness—Etoposide—germ cell cancer	0.000244	0.00149	CcSEcCtD
Meloxicam—Nervous system disorder—Cisplatin—germ cell cancer	0.000242	0.00148	CcSEcCtD
Meloxicam—Cough—Etoposide—germ cell cancer	0.000242	0.00148	CcSEcCtD
Meloxicam—Thrombocytopenia—Cisplatin—germ cell cancer	0.000242	0.00148	CcSEcCtD
Meloxicam—Tachycardia—Cisplatin—germ cell cancer	0.000241	0.00148	CcSEcCtD
Meloxicam—Asthenia—Bleomycin—germ cell cancer	0.00024	0.00147	CcSEcCtD
Meloxicam—Convulsion—Etoposide—germ cell cancer	0.00024	0.00147	CcSEcCtD
Meloxicam—Skin disorder—Cisplatin—germ cell cancer	0.00024	0.00147	CcSEcCtD
Meloxicam—Hypertension—Etoposide—germ cell cancer	0.000239	0.00147	CcSEcCtD
Meloxicam—Hyperhidrosis—Cisplatin—germ cell cancer	0.000239	0.00146	CcSEcCtD
Meloxicam—Asthma—Methotrexate—germ cell cancer	0.000238	0.00146	CcSEcCtD
Meloxicam—Pruritus—Bleomycin—germ cell cancer	0.000237	0.00145	CcSEcCtD
Meloxicam—Feeling abnormal—Ifosfamide—germ cell cancer	0.000236	0.00145	CcSEcCtD
Meloxicam—Nausea—Vinblastine—germ cell cancer	0.000236	0.00144	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000234	0.00144	CcSEcCtD
Meloxicam—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000234	0.00144	CcSEcCtD
Meloxicam—Pancreatitis—Methotrexate—germ cell cancer	0.000234	0.00143	CcSEcCtD
Meloxicam—Discomfort—Etoposide—germ cell cancer	0.000233	0.00143	CcSEcCtD
Meloxicam—Hypotension—Cisplatin—germ cell cancer	0.000231	0.00141	CcSEcCtD
Meloxicam—Hypersensitivity—Dactinomycin—germ cell cancer	0.00023	0.00141	CcSEcCtD
Meloxicam—Abdominal discomfort—Methotrexate—germ cell cancer	0.000228	0.0014	CcSEcCtD
Meloxicam—Confusional state—Etoposide—germ cell cancer	0.000228	0.0014	CcSEcCtD
Meloxicam—Urticaria—Ifosfamide—germ cell cancer	0.000228	0.00139	CcSEcCtD
Meloxicam—Abdominal pain—Ifosfamide—germ cell cancer	0.000226	0.00139	CcSEcCtD
Meloxicam—Body temperature increased—Ifosfamide—germ cell cancer	0.000226	0.00139	CcSEcCtD
Meloxicam—Pancytopenia—Methotrexate—germ cell cancer	0.000226	0.00139	CcSEcCtD
Meloxicam—Anaphylactic shock—Etoposide—germ cell cancer	0.000226	0.00139	CcSEcCtD
Meloxicam—PTGS1—brain—germ cell cancer	0.000226	0.0037	CbGeAlD
Meloxicam—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000225	0.00138	CcSEcCtD
Meloxicam—Infection—Etoposide—germ cell cancer	0.000225	0.00138	CcSEcCtD
Meloxicam—Asthenia—Dactinomycin—germ cell cancer	0.000224	0.00137	CcSEcCtD
Meloxicam—Paraesthesia—Cisplatin—germ cell cancer	0.000222	0.00136	CcSEcCtD
Meloxicam—Thrombocytopenia—Etoposide—germ cell cancer	0.000222	0.00136	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000221	0.00136	CcSEcCtD
Meloxicam—Tachycardia—Etoposide—germ cell cancer	0.000221	0.00135	CcSEcCtD
Meloxicam—Dyspnoea—Cisplatin—germ cell cancer	0.00022	0.00135	CcSEcCtD
Meloxicam—Skin disorder—Etoposide—germ cell cancer	0.00022	0.00135	CcSEcCtD
Meloxicam—Hyperhidrosis—Etoposide—germ cell cancer	0.000219	0.00134	CcSEcCtD
Meloxicam—PTGS1—lymph node—germ cell cancer	0.000218	0.00358	CbGeAlD
Meloxicam—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000218	0.00133	CcSEcCtD
Meloxicam—PTGS2—brain—germ cell cancer	0.000216	0.00354	CbGeAlD
Meloxicam—Decreased appetite—Cisplatin—germ cell cancer	0.000215	0.00132	CcSEcCtD
Meloxicam—Diarrhoea—Dactinomycin—germ cell cancer	0.000214	0.00131	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000213	0.00131	CcSEcCtD
Meloxicam—Vomiting—Bleomycin—germ cell cancer	0.000213	0.00131	CcSEcCtD
Meloxicam—Infestation—Methotrexate—germ cell cancer	0.000212	0.0013	CcSEcCtD
Meloxicam—Infestation NOS—Methotrexate—germ cell cancer	0.000212	0.0013	CcSEcCtD
Meloxicam—Drowsiness—Methotrexate—germ cell cancer	0.000212	0.0013	CcSEcCtD
Meloxicam—Hypotension—Etoposide—germ cell cancer	0.000211	0.0013	CcSEcCtD
Meloxicam—Rash—Bleomycin—germ cell cancer	0.000211	0.0013	CcSEcCtD
Meloxicam—Pain—Cisplatin—germ cell cancer	0.000211	0.00129	CcSEcCtD
Meloxicam—Dermatitis—Bleomycin—germ cell cancer	0.000211	0.00129	CcSEcCtD
Meloxicam—Hypersensitivity—Ifosfamide—germ cell cancer	0.000211	0.00129	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000211	0.00129	CcSEcCtD
Meloxicam—Renal failure—Methotrexate—germ cell cancer	0.000209	0.00128	CcSEcCtD
Meloxicam—PTGS2—lymph node—germ cell cancer	0.000208	0.00342	CbGeAlD
Meloxicam—Stomatitis—Methotrexate—germ cell cancer	0.000207	0.00127	CcSEcCtD
Meloxicam—Conjunctivitis—Methotrexate—germ cell cancer	0.000207	0.00127	CcSEcCtD
Meloxicam—Asthenia—Ifosfamide—germ cell cancer	0.000206	0.00126	CcSEcCtD
Meloxicam—Sweating—Methotrexate—germ cell cancer	0.000204	0.00125	CcSEcCtD
Meloxicam—Feeling abnormal—Cisplatin—germ cell cancer	0.000204	0.00125	CcSEcCtD
Meloxicam—Paraesthesia—Etoposide—germ cell cancer	0.000203	0.00125	CcSEcCtD
Meloxicam—Pruritus—Ifosfamide—germ cell cancer	0.000203	0.00124	CcSEcCtD
Meloxicam—Haematuria—Methotrexate—germ cell cancer	0.000203	0.00124	CcSEcCtD
Meloxicam—Dyspnoea—Etoposide—germ cell cancer	0.000202	0.00124	CcSEcCtD
Meloxicam—Somnolence—Etoposide—germ cell cancer	0.000201	0.00123	CcSEcCtD
Meloxicam—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000201	0.00123	CcSEcCtD
Meloxicam—Nausea—Bleomycin—germ cell cancer	0.000199	0.00122	CcSEcCtD
Meloxicam—Vomiting—Dactinomycin—germ cell cancer	0.000199	0.00122	CcSEcCtD
Meloxicam—Agranulocytosis—Methotrexate—germ cell cancer	0.000198	0.00122	CcSEcCtD
Meloxicam—Rash—Dactinomycin—germ cell cancer	0.000197	0.00121	CcSEcCtD
Meloxicam—Decreased appetite—Etoposide—germ cell cancer	0.000197	0.00121	CcSEcCtD
Meloxicam—Diarrhoea—Ifosfamide—germ cell cancer	0.000196	0.0012	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000195	0.0012	CcSEcCtD
Meloxicam—Body temperature increased—Cisplatin—germ cell cancer	0.000195	0.0012	CcSEcCtD
Meloxicam—Fatigue—Etoposide—germ cell cancer	0.000195	0.0012	CcSEcCtD
Meloxicam—Constipation—Etoposide—germ cell cancer	0.000193	0.00119	CcSEcCtD
Meloxicam—Pain—Etoposide—germ cell cancer	0.000193	0.00119	CcSEcCtD
Meloxicam—Haemoglobin—Methotrexate—germ cell cancer	0.000192	0.00117	CcSEcCtD
Meloxicam—Haemorrhage—Methotrexate—germ cell cancer	0.000191	0.00117	CcSEcCtD
Meloxicam—Hepatitis—Methotrexate—germ cell cancer	0.000191	0.00117	CcSEcCtD
Meloxicam—Dizziness—Ifosfamide—germ cell cancer	0.000189	0.00116	CcSEcCtD
Meloxicam—Pharyngitis—Methotrexate—germ cell cancer	0.000189	0.00116	CcSEcCtD
Meloxicam—Urinary tract disorder—Methotrexate—germ cell cancer	0.000188	0.00115	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—germ cell cancer	0.000187	0.00115	CcSEcCtD
Meloxicam—Feeling abnormal—Etoposide—germ cell cancer	0.000186	0.00114	CcSEcCtD
Meloxicam—Nausea—Dactinomycin—germ cell cancer	0.000186	0.00114	CcSEcCtD
Meloxicam—Gastrointestinal pain—Etoposide—germ cell cancer	0.000185	0.00113	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—germ cell cancer	0.000184	0.00113	CcSEcCtD
Meloxicam—Vomiting—Ifosfamide—germ cell cancer	0.000182	0.00112	CcSEcCtD
Meloxicam—Hypersensitivity—Cisplatin—germ cell cancer	0.000182	0.00112	CcSEcCtD
Meloxicam—Rash—Ifosfamide—germ cell cancer	0.000181	0.00111	CcSEcCtD
Meloxicam—Dermatitis—Ifosfamide—germ cell cancer	0.00018	0.00111	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—germ cell cancer	0.00018	0.00111	CcSEcCtD
Meloxicam—Urticaria—Etoposide—germ cell cancer	0.00018	0.0011	CcSEcCtD
Meloxicam—Abdominal pain—Etoposide—germ cell cancer	0.000179	0.0011	CcSEcCtD
Meloxicam—Body temperature increased—Etoposide—germ cell cancer	0.000179	0.0011	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—germ cell cancer	0.000178	0.00109	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—germ cell cancer	0.000178	0.00109	CcSEcCtD
Meloxicam—Asthenia—Cisplatin—germ cell cancer	0.000177	0.00109	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—germ cell cancer	0.000177	0.00108	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—germ cell cancer	0.000173	0.00106	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—germ cell cancer	0.000172	0.00106	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—germ cell cancer	0.000172	0.00105	CcSEcCtD
Meloxicam—Nausea—Ifosfamide—germ cell cancer	0.00017	0.00104	CcSEcCtD
Meloxicam—Diarrhoea—Cisplatin—germ cell cancer	0.000169	0.00104	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—germ cell cancer	0.000169	0.00103	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—germ cell cancer	0.000167	0.00102	CcSEcCtD
Meloxicam—Hypersensitivity—Etoposide—germ cell cancer	0.000167	0.00102	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—germ cell cancer	0.000166	0.00102	CcSEcCtD
Meloxicam—Erythema—Methotrexate—germ cell cancer	0.000166	0.00102	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—germ cell cancer	0.000163	0.000997	CcSEcCtD
Meloxicam—Asthenia—Etoposide—germ cell cancer	0.000162	0.000995	CcSEcCtD
Meloxicam—Back pain—Methotrexate—germ cell cancer	0.000161	0.000984	CcSEcCtD
Meloxicam—Pruritus—Etoposide—germ cell cancer	0.00016	0.000981	CcSEcCtD
Meloxicam—Vomiting—Cisplatin—germ cell cancer	0.000157	0.000962	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—germ cell cancer	0.000156	0.000959	CcSEcCtD
Meloxicam—Rash—Cisplatin—germ cell cancer	0.000156	0.000954	CcSEcCtD
Meloxicam—Dermatitis—Cisplatin—germ cell cancer	0.000156	0.000953	CcSEcCtD
Meloxicam—Diarrhoea—Etoposide—germ cell cancer	0.000155	0.000949	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—germ cell cancer	0.000154	0.000944	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—germ cell cancer	0.000153	0.000941	CcSEcCtD
Meloxicam—Malaise—Methotrexate—germ cell cancer	0.00015	0.000918	CcSEcCtD
Meloxicam—Dizziness—Etoposide—germ cell cancer	0.00015	0.000917	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—germ cell cancer	0.000149	0.000914	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—germ cell cancer	0.000149	0.000911	CcSEcCtD
Meloxicam—Nausea—Cisplatin—germ cell cancer	0.000147	0.000899	CcSEcCtD
Meloxicam—Cough—Methotrexate—germ cell cancer	0.000145	0.000888	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—germ cell cancer	0.000144	0.000882	CcSEcCtD
Meloxicam—Vomiting—Etoposide—germ cell cancer	0.000144	0.000882	CcSEcCtD
Meloxicam—Rash—Etoposide—germ cell cancer	0.000143	0.000874	CcSEcCtD
Meloxicam—Dermatitis—Etoposide—germ cell cancer	0.000143	0.000873	CcSEcCtD
Meloxicam—Headache—Etoposide—germ cell cancer	0.000142	0.000869	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—germ cell cancer	0.000141	0.000866	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—germ cell cancer	0.000141	0.000866	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00014	0.00086	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—germ cell cancer	0.00014	0.000856	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—germ cell cancer	0.000137	0.000837	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—germ cell cancer	0.000136	0.000831	CcSEcCtD
Meloxicam—Infection—Methotrexate—germ cell cancer	0.000135	0.000825	CcSEcCtD
Meloxicam—Nausea—Etoposide—germ cell cancer	0.000134	0.000824	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—germ cell cancer	0.000133	0.000815	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—germ cell cancer	0.000133	0.000813	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—germ cell cancer	0.000132	0.000807	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—germ cell cancer	0.000131	0.000803	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—germ cell cancer	0.000127	0.000776	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000123	0.000757	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—germ cell cancer	0.000123	0.000751	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—germ cell cancer	0.000122	0.000746	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—germ cell cancer	0.000121	0.00074	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—germ cell cancer	0.00012	0.000738	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—germ cell cancer	0.000119	0.000731	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—germ cell cancer	0.000118	0.000722	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000117	0.000717	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—germ cell cancer	0.000117	0.000716	CcSEcCtD
Meloxicam—Pain—Methotrexate—germ cell cancer	0.000116	0.00071	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—germ cell cancer	0.000112	0.000684	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000111	0.000679	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—germ cell cancer	0.000108	0.00066	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—germ cell cancer	0.000107	0.000657	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—germ cell cancer	0.000107	0.000657	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—germ cell cancer	9.98e-05	0.000612	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—germ cell cancer	9.72e-05	0.000596	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—germ cell cancer	9.59e-05	0.000588	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—germ cell cancer	9.27e-05	0.000568	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—germ cell cancer	8.96e-05	0.000549	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—germ cell cancer	8.62e-05	0.000528	CcSEcCtD
Meloxicam—Rash—Methotrexate—germ cell cancer	8.54e-05	0.000524	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—germ cell cancer	8.54e-05	0.000523	CcSEcCtD
Meloxicam—Headache—Methotrexate—germ cell cancer	8.49e-05	0.00052	CcSEcCtD
Meloxicam—Nausea—Methotrexate—germ cell cancer	8.05e-05	0.000493	CcSEcCtD
